Pfizer Inc Stock Analysis

PFE Stock  USD 27.55  0.12  0.43%   
Pfizer Inc is undervalued with Real Value of 31.68 and Target Price of 38.67. The main objective of Pfizer stock analysis is to determine its intrinsic value, which is an estimate of what Pfizer Inc is worth, separate from its market price. There are two main types of Pfizer's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Pfizer's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Pfizer's stock to identify patterns and trends that may indicate its future price movements.
The Pfizer stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Pfizer is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. Pfizer Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Pfizer's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in census.

Pfizer Stock Analysis Notes

About 70.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.61. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc has Price/Earnings To Growth (PEG) ratio of 1.17. The entity last dividend was issued on the 25th of January 2024. The firm had 1054:1000 split on the 17th of November 2020. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. Pfizer operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 79000 people. To find out more about Pfizer Inc contact DVM DVM at 212 733 2323 or learn more at https://www.pfizer.com.

Pfizer Quarterly Total Revenue

13.23 Billion

Pfizer Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Pfizer's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Pfizer Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Pfizer Inc generated a negative expected return over the last 90 days
Pfizer Inc has a poor financial position based on the latest SEC disclosures
About 70.0% of the company shares are owned by institutional investors
Latest headline from seekingalpha.com: Stifel starts Celcuity at buy, sees gedatolisib as potential blockbuster

Pfizer Inc Upcoming and Recent Events

Earnings reports are used by Pfizer to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Pfizer previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of May 2024
Upcoming Quarterly Report
View
6th of August 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
4th of February 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

Pfizer Largest EPS Surprises

Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-07-19
1999-06-300.170.190.0211 
1998-10-13
1998-09-300.190.17-0.0210 
1998-07-09
1998-06-300.150.170.0213 
View All Earnings Estimates

Pfizer SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Pfizer prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Pfizer investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Pfizer Inc specific information freely available to individual and institutional investors to make a timely investment decision.
14th of February 2024
Unclassified Corporate Event
View
13th of February 2024
Unclassified Corporate Event
View
30th of January 2024
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
29th of January 2024
Unclassified Corporate Event. Unclassified Corporate Event
View
26th of January 2024
Unclassified Corporate Event
View
19th of January 2024
Unclassified Corporate Event
View
10th of January 2024
Financial Statements and Exhibits. Other Events. Unclassified Corporate Event
View
14th of December 2023
Financial Statements and Exhibits. Regulation FD Disclosure. Results of Operations and Financial Condition. Completion of Acquisition or Disposition of Assets
View

Pfizer Thematic Classifications

In addition to having Pfizer stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Robots And Drones Idea
Robots And Drones
Cross-sector firms and funds that develop or invest in technology that can replicate repetitive human actions

Pfizer Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer Inc backward and forwards among themselves. Pfizer's institutional investor refers to the entity that pools money to purchase Pfizer's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Farm Mutual Automobile Ins Co2023-12-31
54.5 M
Bank Of America Corp2023-09-30
52.2 M
Bank Of New York Mellon Corp2023-09-30
49.3 M
Legal & General Group Plc2023-09-30
42.5 M
Dimensional Fund Advisors, Inc.2023-12-31
42 M
Jpmorgan Chase & Co2023-09-30
41.5 M
Amundi2023-09-30
38.5 M
Deutsche Bank Ag2023-09-30
36.6 M
T. Rowe Price Associates, Inc.2023-12-31
30.5 M
Vanguard Group Inc2023-09-30
506.7 M
Blackrock Inc2023-09-30
438.9 M
Note, although Pfizer's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pfizer Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 156.24 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Pfizer's market, we take the total number of its shares issued and multiply it by Pfizer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Pfizer Profitablity

Pfizer's profitability indicators refer to fundamental financial ratios that showcase Pfizer's ability to generate income relative to its revenue or operating costs. If, let's say, Pfizer is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Pfizer's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Pfizer's profitability requires more research than a typical breakdown of Pfizer's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.04 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of (0.09) %, which entails that for every $100 of revenue, it lost $0.09.
Last ReportedProjected for 2024
Return on Investment 25.87  27.91 
Return on Average Assets 0.19  0.15 
Return on Average Equity 0.40  0.34 
Return on Invested Capital 0.39  0.42 
Return on Sales 0.31  0.28 

Management Efficiency

Pfizer Inc has Return on Asset of 0.0539 % which means that on every $100 spent on assets, it made $0.0539 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0225 %, implying that it generated $0.0225 on every 100 dollars invested. Pfizer's management efficiency ratios could be used to measure how well Pfizer manages its routine affairs as well as how well it operates its assets and liabilities. At present, Pfizer's Return on Invested Capital is projected to increase slightly based on the last few years of reporting. The current year's Net Current Assets as percentage of Total Assets is expected to grow to 5.46, whereas Total Assets are forecasted to decline to about 218.4 B.
Last ReportedProjected for 2024
Book Value per Share 19.62  17.22 
Enterprise Value over EBIT 8.10  12.64 
Enterprise Value over EBITDA 9.34  12.79 
Price to Book Value 3.46  3.72 
Tangible Assets Book Value per Share 21.01  19.20 
Enterprise Value371.4 B352.4 B
Tangible Asset Value117.8 B110.2 B
The analysis of Pfizer's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Pfizer's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Pfizer Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0607
Forward Dividend Yield
0.0607
Forward Dividend Rate
1.68
Beta
0.568

Technical Drivers

As of the 23rd of February, Pfizer holds the Variance of 3.1, risk adjusted performance of (0.03), and Coefficient Of Variation of (1,729). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pfizer, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to analyze and collect data for thirteen technical drivers for Pfizer Inc, which can be compared to its competitors. Please check Pfizer Inc standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and kurtosis to decide if Pfizer Inc is priced some-what accurately, providing market reflects its current price of 27.55 per share. Given that Pfizer has information ratio of (0.15), we recommend you to check out Pfizer Inc's recent market performance to make sure the company can sustain itself at a future point.

Pfizer Inc Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Pfizer middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Pfizer Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
.

Pfizer Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Pfizer insiders, such as employees or executives, is commonly permitted as long as it does not rely on Pfizer's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Pfizer insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Pfizer Outstanding Bonds

Pfizer issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Pfizer Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Pfizer bonds can be classified according to their maturity, which is the date when Pfizer Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Pfizer Predictive Daily Indicators

Pfizer intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Pfizer stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Pfizer Forecast Models

Pfizer's time-series forecasting models are one of many Pfizer's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pfizer's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Pfizer Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pfizer prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pfizer shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pfizer. By using and applying Pfizer Stock analysis, traders can create a robust methodology for identifying Pfizer entry and exit points for their positions.
Last ReportedProjected for 2024
Operating Margin 31.86  26.42 
EBITDA Margin 0.36  0.36 
Gross Margin 0.59  0.63 
Profit Margin 0.36  0.35 

Current Pfizer Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pfizer analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pfizer analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
38.67Buy25Odds
Pfizer Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Pfizer analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Pfizer stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Pfizer Inc, talking to its executives and customers, or listening to Pfizer conference calls.
Pfizer Analyst Advice Details

Pfizer Stock Analysis Indicators

Pfizer Inc stock analysis indicators help investors evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pfizer shares will generate the highest return on investment. By understating and applying Pfizer stock analysis, traders can identify Pfizer position entry and exit signals to maximize returns.
Begin Period Cash Flow468 M
Long Term Debt32.9 B
Common Stock Shares Outstanding5.7 B
Total Stockholder Equity95.7 B
Tax Provision3.3 B
Quarterly Earnings Growth Y O Y-0.764
Property Plant And Equipment Net16.3 B
Cash And Short Term Investments22.7 B
Cash416 M
Accounts Payable6.8 B
Net Debt34.5 B
50 Day M A28.0042
Total Current Liabilities42.1 B
Other Operating Expenses63.1 B
Non Current Assets Total145.9 B
Forward Price Earnings12.4688
Common Stock Total Equity476 M
Non Currrent Assets Other13.2 B
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pfizer Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.